Intuitive Surgical (ISRG) PT Raised to $700 at Piper Jaffray But Risk/Reward Keeps Them Sidelined

Intuitive Surgical (ISRG) PT Raised to $750 at Canaccord Genuity; 'Hitting on All Cylinders'

Canaccord Genuity analyst Jason Mills reiterated a Buy rating and lifted his price target on Intuitive Surgical (NASDAQ: ISRG) to $750.00 (from $700.00) following strong results. Mills said the company is hitting on all cylinders and riding a tailwind with multiple levers still to pull.

Mills commented, "Viva la Robolucion! We made this proclamation coming out of the SAGES conference in March, repeated it after robust Q1 results, and reiterate it after the... More

Intuitive Surgical (ISRG) PT Raised to $775 at Evercore ISI

Evercore ISI analyst Vijay Kumar reiterated a Buy rating and raised estimates and his price target on Intuitive Surgical (NASDAQ: ISRG) to $775.00 (from $750.00) following strong results. The firm is raising estimates for FY17 EPS from prior $24.50 to $25.25 and FY18 from $27.50 to $28.65.

What they liked in the quarter:

1) Procedures came in above guidance (16%) and... More

Intuitive Surgical (ISRG) PT Raised to $78 at Leerink Partners Following Another 'Beat and Raise'

Leerink Partners analyst Richard Newitter reiterated an Outperform rating and boosted his price target on Intuitive Surgical (NASDAQ: ISRG) to $780.00 (from $710.00) on beat & raise.

Newitter comments, "We remain bullish on ISRG amid an improving procedure & GM outlook plus new prod cycle momentum... More

BTIG Loves Intuitive Surgical's (ISRG) Business, But Remains Sidelined on the Stock

BTIG affirms Intuitive Surgical (Nasdaq: ISRG) with a Neutral rating following Q2 results issued Tuesday night.

Analyst Sean Lavin commented today: Once again procedures impressed, up 16% y/y. We discussed this in our preview modeling 14%, above consensus of 13%. Additionally systems... More

Intuitive Surgical (ISRG) PT Raised to $755 at Wedbush

Wedbush analyst Tao Levy reiterated an Outperform raring and lifted its price target on Intuitive Surgical (NASDAQ: ISRG) to $755.00 (from $715.00) following strong Q2 results.

"Intuitive Surgical handily exceeded 2Q expectations, including an eighth consecutive quarter of double-digit procedure growth," Levy commented.... More

Intuitive Surgical (ISRG) Tops Q2 EPS by 65c

Intuitive Surgical (NASDAQ: ISRG) reported Q2 EPS of $5.62, $0.65 better than the analyst estimate of $4.97. Revenue for the quarter came in at $670 million versus the consensus estimate of $640.69 million.

Commenting on the announcement, Dr. Gary Guthart, President and CEO of Intuitive Surgical, said, We... More